These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 3042210)

  • 1. Tolerance of engrafted donor T cells following bone marrow transplantation for severe combined immunodeficiency.
    Keever CA; Flomenberg N; Brochstein J; Sullivan M; Collins NH; Burns J; Dupont B; O'Reilly RJ
    Clin Immunol Immunopathol; 1988 Sep; 48(3):261-76. PubMed ID: 3042210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytotoxic and proliferative T-cell clones with antidonor reactivity from a patient transplanted for severe combined immunodeficiency disease.
    Keever CA; Flomenberg N; Gazzola MV; Pekle K; Yang SY; Small TN; Collins NH; O'Reilly RJ
    Hum Immunol; 1990 Sep; 29(1):42-55. PubMed ID: 2211189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of tolerance associated with disappearance of B cells in a patient sequentially transplanted with paternal and maternal bone marrow for the treatment of severe combined immunodeficiency disease.
    Keever CA; Flomenberg N; Small T; Brochstein J; Collins N; Young-Yang S; Insel R; Dupont B; O'Reilly RJ
    Hum Immunol; 1989 Sep; 26(1):27-38. PubMed ID: 2528525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Self-tolerance to host and donor following HLA-mismatched bone marrow transplantation.
    De Villartay JP; Griscelli C; Fischer A
    Eur J Immunol; 1986 Feb; 16(2):117-22. PubMed ID: 3514234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chimerism and tolerance to host and donor in severe combined immunodeficiencies transplanted with fetal liver stem cells.
    Bacchetta R; Vandekerckhove BA; Touraine JL; Bigler M; Martino S; Gebuhrer L; de Vries JE; Spits H; Roncarolo MG
    J Clin Invest; 1993 Mar; 91(3):1067-78. PubMed ID: 8450037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of tolerance after haplocompatible T-depleted bone marrow transplantation.
    Merino A; Dror Y; Benkerrou M; Colombe BW; Cowan MJ
    Bone Marrow Transplant; 1993 Nov; 12(5):483-8. PubMed ID: 8298559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modified MHC restriction of donor-origin T cells in humans with severe combined immunodeficiency transplanted with haploidentical bone marrow stem cells.
    Roberts JL; Volkman DJ; Buckley RH
    J Immunol; 1989 Sep; 143(5):1575-9. PubMed ID: 2474604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modified responses to recipient and donor B cells by genetically donor T cells from human haploidentical bone marrow chimeras.
    Schiff SE; Buckley RH
    J Immunol; 1987 Apr; 138(7):2088-94. PubMed ID: 2881966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD3+ T cells in severe combined immunodeficiency (scid) mice. II. Transplantation of dm2 lymphoid cells into semi-allogeneic scid mice.
    Rudolphi A; Spiess S; Conradt P; Claesson MH; Reimann J
    Eur J Immunol; 1991 Jul; 21(7):1591-600. PubMed ID: 1829409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reconstitution after transplantation with T-lymphocyte-depleted HLA haplotype-mismatched bone marrow for severe combined immunodeficiency.
    Reinherz EL; Geha R; Rappeport JM; Wilson M; Penta AC; Hussey RE; Fitzgerald KA; Daley JF; Levine H; Rosen FS; Schlossman SF
    Proc Natl Acad Sci U S A; 1982 Oct; 79(19):6047-51. PubMed ID: 6764536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dysfunctional cytokine production by host-reactive T-cell clones isolated from a chimeric severe combined immunodeficiency patient transplanted with haploidentical bone marrow.
    Bacchetta R; Parkman R; McMahon M; Weinberg K; Bigler M; de Vries JE; Roncarolo MG
    Blood; 1995 Apr; 85(7):1944-53. PubMed ID: 7703497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence that appearance of thymulin in plasma follows lymphoid chimerism and precedes development of immunity in patients with lethal combined immunodeficiency transplanted with T cell-depleted haploidentical marrow.
    Incefy GS; Flomenberg N; Heller G; Kernan NA; Brochstein J; Kirkpatrick D; Kapoor N; Groshen S; O'Reilly RJ
    Transplantation; 1990 Jul; 50(1):55-61. PubMed ID: 2368151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mixed allogeneic reconstitution (A+B----A) to induce donor-specific transplantation tolerance. Permanent acceptance of a simultaneous donor skin graft.
    Ildstad ST; Wren SM; Oh E; Hronakes ML
    Transplantation; 1991 Jun; 51(6):1262-7. PubMed ID: 1828637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of selective T cell depletion of host and/or donor bone marrow on lymphopoietic repopulation, tolerance, and graft-vs-host disease in mixed allogeneic chimeras (B10 + B10.D2----B10).
    Ildstad ST; Wren SM; Bluestone JA; Barbieri SA; Stephany D; Sachs DH
    J Immunol; 1986 Jan; 136(1):28-33. PubMed ID: 2933464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accelerated development of immunity following transplantation of maternal marrow stem cells into infants with severe combined immunodeficiency and transplacentally acquired lymphoid chimerism.
    Barrett MJ; Buckley RH; Schiff SE; Kidd PC; Ward FE
    Clin Exp Immunol; 1988 Apr; 72(1):118-23. PubMed ID: 3293848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The evolution of MHC restrictions in antigen recognition by T cells in a haploidentical bone marrow transplant recipient.
    Geha RS; Rosen FS
    J Immunol; 1989 Jul; 143(1):84-8. PubMed ID: 2567317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Haploidentical bone marrow transplantation for severe combined immunodeficiency disease using soybean agglutinin-negative, T-depleted marrow cells.
    Cowan MJ; Wara DW; Weintrub PS; Pabst H; Ammann AJ
    J Clin Immunol; 1985 Nov; 5(6):370-6. PubMed ID: 3910675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of immunity in human severe primary T cell deficiency following haploidentical bone marrow stem cell transplantation.
    Buckley RH; Schiff SE; Sampson HA; Schiff RI; Markert ML; Knutsen AP; Hershfield MS; Huang AT; Mickey GH; Ward FE
    J Immunol; 1986 Apr; 136(7):2398-407. PubMed ID: 2869085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multilineage engraftment with minimal graft-versus-host disease following in utero transplantation of S-59 psoralen/ultraviolet a light-treated, sensitized T cells and adult T cell-depleted bone marrow in fetal mice.
    Bhattacharyya S; Chawla A; Smith K; Zhou Y; Talib S; Wardwell B; Cowan MJ
    J Immunol; 2002 Dec; 169(11):6133-40. PubMed ID: 12444116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Both ongoing suppression and clonal elimination contribute to graft-host tolerance after transplantation of HLA mismatched T cell-depleted marrow for severe combined immunodeficiency.
    Rosenkrantz K; Keever C; Bhimani K; Horvath A; Brochstein J; O'Reilly R; Dupont B; Flomenberg N
    J Immunol; 1990 Mar; 144(5):1721-8. PubMed ID: 2307837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.